Acro Biomedical (ACBM) Price to Earnings (2018 - 2026)

Acro Biomedical has reported Price to Earnings for 9 years, with the latest figure at 102.61 in Q2 2026.

• On a quarterly basis, Price to Earnings changed N/A year-over-year to 102.61 in Q2 2026; TTM through Jun 2026 was 20.67, a N/A change from a year earlier, with the FY2025 full-year figure at 11.95, changed N/A from the prior year.
• Price to Earnings was 102.61 for Q2 2026 at Acro Biomedical, down from 18.83 in the prior quarter.
• The five-year high for Price to Earnings was 18.83 in Q4 2025, with the low at 591.96 in Q2 2024.
• Average Price to Earnings over 5 years is 133.45, with a median of 62.43 recorded in 2022.
• The sharpest annual moves came in 2023 and 2024: Price to Earnings surged 104.77% in 2023, then sank 2639.51% in 2024.
• Over 5 years, Price to Earnings stood at 68.67 in 2022, then soared by 104.77% to 3.28 in 2023, then plunged by 18155.31% to 591.96 in 2024, then surged by 103.18% to 18.83 in 2025, then tumbled by 644.89% to 102.61 in 2026.
• The last three Price to Earnings figures came in at 102.61 (Q2 2026), 18.83 (Q4 2025), and 591.96 (Q2 2024), per Business Quant data.